Abstract
The article has been withdrawn at the request of the Editor of the journal Coronaviruses. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.
The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php
BENTHAM SCIENCE DISCLAIMER:
It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submit- ting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
Coronaviruses
Title:Withdrawal Notice: Current Drug Trends for the Treatment of the SARS- CoV-2
Volume: 1
Author(s): Márcio Robert Mattos da Silva*, Melanie Tavares, Ralph Santos-Oliveira and Eduardo RicciJúnior
Affiliation:
- Faculty of Pharmacy, Galenic Development Laboratory (LADEG), Department of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro,Brazil
Abstract: The article has been withdrawn at the request of the Editor of the journal Coronaviruses. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.
The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php
BENTHAM SCIENCE DISCLAIMER:
It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submit- ting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
Export Options
About this article
Cite this article as:
da Silva Robert Mattos Márcio *, Tavares Melanie , Santos-Oliveira Ralph and RicciJúnior Eduardo , Withdrawal Notice: Current Drug Trends for the Treatment of the SARS- CoV-2, Coronaviruses 2020; 1 () . https://dx.doi.org/10.2174/2666796701999201222114336
DOI https://dx.doi.org/10.2174/2666796701999201222114336 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Interleukin-6 in the Pathogenesis, Prognosis and Treatment of Severe COVID-19
Current Medicinal Chemistry Recent Patents on Treatment of Severe Acute Respiratory Syndrome (SARS)
Recent Patents on Anti-Infective Drug Discovery Chimeric Virus-like Particles of Universal Antigen Epitopes of Coronavirus and Phage Qβ Coat Protein Trigger the Production of Neutralizing Antibodies
Current Topics in Medicinal Chemistry Research and Patents on Coronavirus and COVID-19: A Review
Recent Patents on Nanotechnology Exploitation of Some Natural Products for the Prevention and/or Nutritional Treatment of SARS-CoV2 Infection
Endocrine, Metabolic & Immune Disorders - Drug Targets COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods
Anti-Cancer Agents in Medicinal Chemistry SARS: Understanding the Virus and Development of Rational Therapy
Current Molecular Medicine Insights into Novel Coronavirus Disease 2019 (COVID-19): Current Understanding, Research, and Therapeutic Updates
Recent Patents on Biotechnology Effectiveness of Antiviral and Immunomodulatory Agents in the Treatment of COVID-19: A Systematic Review
Current Respiratory Medicine Reviews Predicting Protein-Ligand Binding Sites Based on an Improved Geometric Algorithm
Protein & Peptide Letters Anticipating a Post COVID-19 World and the Pivotal Role of Science and Technology
Coronaviruses Focused Microarray Analysis: Characterization of Phenomes by Gene Expression Profiling
Current Pharmacogenomics ACE and ACE2 in Inflammation: A Tale of Two Enzymes
Inflammation & Allergy - Drug Targets (Discontinued) Molecular Modeling Studies of Peptide Drug Candidates against SARS
Medicinal Chemistry Update of QSAR & Docking Studies of the GSK-3 Inhibitors
Current Bioinformatics Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19
Current Pharmaceutical Design Anxiety, Insomnia and Body Mass Index Scores in Italian Nurses Engaged in the Care of COVID-19 Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets ACE2; an ACE up the Sleeve?
Current Enzyme Inhibition SVM Prediction of Ligand-binding Sites in Bacterial Lipoproteins Employing Shape and Physio-chemical Descriptors
Protein & Peptide Letters Viral Evolution will Automatically Resolve COVID-19 Pandemic
Combinatorial Chemistry & High Throughput Screening